Fabtech Technologies Limited

Q3 FY26 saw a dip in top and bottom lines primarily due to timing issues, with approximately 20.3 crores of material stock delayed at the port and subsequently deferred for revenue recognition to Q4 FY26. This was compounded by front-loaded costs in Q3, which are expected to be offset by back-ended revenue in Q4. Management emphasized that this softness was timing-related^📎, not demand-related, and the annual guidance remains intact.

As of January 31, 2026, Fabtech reported a robust outstanding order book of 926 crores, predominantly export-focused. Additionally, the company has a 'hot lead bank' or pipeline valued at approximately $455 million, indicating strong future growth potential. The average ticket size for projects has significantly increased from $1.5-5 million to $7-10 million, reflecting a shift towards larger, more complex, and potentially higher-value contracts.

Fabtech positions itself as a design-led, globally positioned life-science infrastructure platform, focusing on pharmaceutical emerging markets in regions like the Middle East, Africa, and GCC. The company aims to contribute to medicinal independence in these geographies by building facilities for generics, IV solutions, oncology, and even biosimilars, with several 'firsts' to its credit in these regions. This strategy is underpinned by an asset-light, lean, and integrated model with in-house GMP expertise and a team of over 180 engineers.

The company is actively pursuing inorganic growth, having raised funds for acquiring a European entity to strengthen its conversion rates and market positioning. Management also indicated that they are 'closing in on a couple of them here in the UAE and in Saudi' and expect these acquisitions to materialize in the first quarter of the next fiscal year. This strategy aims to leverage local presence for preferred partner status and market capture.

Fabtech currently uses a shipment-based revenue recognition method, which can lead to quarterly fluctuations, especially for export-oriented design-build projects. While this method provides payment security through LC-backed projects, management is evaluating a potential switch to a percentage completion method. A decision on this change is expected within the next six months to a year, which could significantly alter revenue reporting.

Fabtech targets a year-on-year growth of 30-40% and aims to maintain PAT margins between 9-11%. The company is focused on improving its order book conversion rate from the current 15% to 20-25%. Efforts are underway to expedite project execution, including addressing civil construction delays from clients and exploring internal infrastructure improvements, as well as green energy solutions. The company acknowledges that operating cash flow will likely remain negative during this high-growth phase due to working capital requirements.